Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

Part of paid clinical trials in Nashville, Tennessee.

Sponsor
Vanderbilt-Ingram Cancer Center
Study ID
NCT06482957
Status
Recruiting
Apply to this trial

Conditions

  • Sarcoma

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Accepted

Interventions

  • Surveys — OTHER
    Complete surveys
  • Blood Collection — OTHER
    Undergo blood collection
  • Saliva Collection — OTHER
    Undergo salvia collection
  • Urine Collection — OTHER
    Undergo urine collection
  • Stool Collection — OTHER
    Undergo stool collection
  • Tissue collection — OTHER
    Undergo tissue collection
  • Physical Activity Monitoring — OTHER
    FitBit will be worn to track physical activity

Study Details

This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.

Key Dates

Start date
Apr 1, 2022
Status verified
Sep 2025
Primary completion
Apr 30, 2028
Completion
Apr 30, 2029

Study Design

Enrollment
2,100 participants (estimated)

Arms

  • Arm: Observational
    Patients monitor physical activity, sedentary behavior, heart rate and sleep wearing a FitBit device, undergo blood urine, stool and/or saliva sample collection, complete surveys and have medical records reviewed throughout study.

Primary Outcome Measure

Impact of disease on adverse oncologic outcomes [ Time Frame: Approximately six years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Vanderbilt University/Ingram Cancer CenterNashvilleTennessee37203
Vanderbilt-Ingram Service for Timely Access
[email protected]
800-811-8480
Debra Friedman, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Nashville, TN

By research site
Vanderbilt University/Ingram Cancer Center· Nashville, TN

Related Studies